Probing Amyloid β and the Antibody Interaction Using Atomic Force Microscopy

被引:3
作者
Han, Sung-Woong [1 ]
Lee, Tae-Hoon [2 ]
Kang, Min-Sik [1 ]
Kim, Hyung Jin [3 ]
Shin, Hoon-Kyu [1 ]
机构
[1] Pohang Univ Sci & Technol, Natl Inst Nanomat Technol, 77 Cheongam Ro, Pohang 37673, Gyeongbuk, South Korea
[2] Dong Yang Ind Co Ltd, Top Run R&D Ctr, 46-14 Okge2gongdan Ro, Gumi 62214, Gyeongbuk, South Korea
[3] Gumi Elect & Informat Technol Res Inst, Convergence Med Device Res Ctr, 350-27 Gumidae Ro, Gumi 39253, Gyeongbuk, South Korea
关键词
Amyloid beta Detection; Immunochemistry; Single Molecular Force Spectroscopy; Atomic Force Microscopy; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; ALPHA;
D O I
10.1166/jnn.2018.14870
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Amyloid beta (A beta) peptide is considered to be the critical causative factor in the pathogenesis of Alzheimer's disease (AD) because the hydrophilic molecules accumulated outside of the neural cells and results in the formation of highly toxicity amyloid plaque. In this study, we probed the interaction between A beta and the antibody using atomic force microscopy (AFM). We compared two kinds of antibodies which are the antibody for A beta 1-42 (antibody42) and the antibody for A beta 1-16 (antibody16). To detect the interaction between A beta and the antibodies, the single molecular force spectroscopy was carried out using A beta modified glass substrate and the antibodies modified AFM probes. In the results, the single A beta-antibody42 dissociation constant was estimated to be 5.2 x 10(-3) s(-1) and the single A beta-antibody16 dissociation constant was 2.8x10(-2) s(-1). The A beta-antibody42 showed 5.3 times longer bond life time compare with A beta-antibody16. It suggested that antibody42 is better choice for the A beta sensor development.
引用
收藏
页码:1410 / 1413
页数:4
相关论文
共 13 条
  • [1] Computational Modeling of Substrate Specificity and Catalysis of the β-Secretase (BACE1) Enzyme
    Barman, Arghya
    Schuerer, Stephan
    Prabhakar, Rajeev
    [J]. BIOCHEMISTRY, 2011, 50 (20) : 4337 - 4349
  • [2] BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575
  • [3] The Development of New Therapeutics for Alzheimer's Disease
    Carter, M. D.
    Simms, G. A.
    Weaver, D. F.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (04) : 475 - 486
  • [4] Biomarkers of Alzheimer's disease
    Craig-Schapiro, Rebecca
    Fagan, Anne M.
    Holtzman, David M.
    [J]. NEUROBIOLOGY OF DISEASE, 2009, 35 (02) : 128 - 140
  • [5] Amyloid-β aggregation
    Finder, Verena H.
    Glockshuber, Rudi
    [J]. NEURODEGENERATIVE DISEASES, 2007, 4 (01) : 13 - 27
  • [6] Activity requires soluble amyloid precursor protein α to promote neurite outgrowth in neural stem cell-derived neurons via activation of the MAPK pathway
    Gakhar-Koppole, Nidhi
    Hundeshagen, Phillip
    Mandl, Claudia
    Weyer, Sascha W.
    Allinquant, Bernadette
    Mueller, Ulrike
    Ciccolini, Francesca
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2008, 28 (05) : 871 - 882
  • [7] Nanolithography of Amyloid Precursor Protein Cleavage with β-Secretase by Atomic Force Microscopy
    Han, Sung-Woong
    Shin, Hoon-Kyu
    Adachi, Taiji
    [J]. JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2016, 12 (03) : 546 - 553
  • [8] Evaluation of Actin Curvature Dependent Actin-Arp2/3 Interaction Change Using AFM and Graphene Oxide Sheets
    Han, Sung-Woong
    Morita, Kyohei
    Adachi, Taiji
    [J]. SCIENCE OF ADVANCED MATERIALS, 2014, 6 (11) : 2453 - 2458
  • [9] A Novel Graphene Oxide-Based Protein Interaction Measurement Using Atomic Force Microscopy
    Han, Sung-Woong
    Morita, Kyohei
    Adachi, Taiji
    [J]. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2015, 15 (02) : 1188 - 1190
  • [10] Interplay between α-, β-, and γ-Secretases Determines Biphasic Amyloid-β Protein Level in the Presence of a γ-Secretase Inhibitor
    Ortega, Fernando
    Stott, Jonathan
    Visser, Sandra A. G.
    Bendtsen, Claus
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (02) : 785 - 792